Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Barcelona Institute for Global Health | OTHER |
Not provided
Not provided
Not provided
Not provided
COVID-19 pneumonia can cause severe acute hypoxemic respiratory failure. The usefulness of noninvasive respiratory support (NIRS), by means of nasal high-flow oxygen (NHFO), continuous positive airway pressure (CPAP), or noninvasive ventilation (NIV), established outside the intensive care unit, is unknown. The aim of this multicenter, retrospective, longitudinal study is to compare the effectiveness of these treatments to prevent death or endotracheal intubation at day 28, and what factors, related to the disease or to the characteristics of the treatment itself, can condition its success or failure.
Multicenter, retrospective, longitudinal study in consecutive adult COVID-19 patients with acute respiratory failure, requiring noninvasive respiratory support (NIRS) outside the intensive care unit (ICU) in 10 hospitals in Catalonia (Spain). Demographic, laboratory, clinical and noninvasive respiratory support data will be collected and analyzed according to the primary outcome (death or endotracheal intubation at day 28) and secondary outcomes (see the dedicated section).
During the hospitalization, patients were treated according to the standard procedures of the participating centers. This study is observational and no randomization have been performed.
Patients were followed up to either 28-days or hospital discharge if still hospitalized at day 28 from NIRS initiation.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| High-flow nasal cannula treatment |
| ||
| Continuous positive airway pressure (CPAP) treatment |
| ||
| Noninvasive ventilation treatment |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| High-flow nasal cannula treatment | Device | Standard operating procedures represented by hihg-flow nasal cannula oxygen therapy |
|
| Measure | Description | Time Frame |
|---|---|---|
| Treatment failure | Death or endotracheal intubation | 28 days within noninvasive respiratory support initiation |
| Measure | Description | Time Frame |
|---|---|---|
| 28-day mortality | 28 days within noninvasive respiratory support initiation | |
| Hospital mortality | Any death during hospital stay | Until 28 days from noninvasive respiratory support initiation |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
COVID19 patients treated by noninvasive respiratory support (nasal high-flow oxygen, CPAP, or noninvasive ventilation), initiated outside the intensive care unit.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Júlia Sampol, MD | Hospital Universitari Vall d'Hebron Research Institute | Study Chair |
| Sergi Marti, MD PhD | Hospital Universitari Vall d'Hebron Research Institute | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospital Germans Trias i Pujol | Badalona | Barcelona | 08916 | Spain | ||
| Hospital General de Granollers |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 35444251 | Derived | Marti S, Carsin AE, Sampol J, Pallero M, Aldas I, Marin T, Lujan M, Lalmolda C, Sabater G, Bonnin-Vilaplana M, Penacoba P, Martinez-Llorens J, Tarrega J, Bernadich O, Cordoba-Izquierdo A, Lozano L, Mendez S, Velez-Segovia E, Prina E, Eizaguirre S, Balana-Corbero A, Ferrer J, Garcia-Aymerich J. Higher mortality and intubation rate in COVID-19 patients treated with noninvasive ventilation compared with high-flow oxygen or CPAP. Sci Rep. 2022 Apr 20;12(1):6527. doi: 10.1038/s41598-022-10475-7. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Continuous positive airway pressure (CPAP) treatment | Device | Standard operating procedures represented by continuous positive airway pressure (CPAP) therapy |
|
| Noninvasive ventilation treatment | Device | Standard operating procedures represented by noninvasive ventilation treatment |
|
| Endotracheal intubation | 28 days within noninvasive respiratory support initiation |
| Duration of hospital stay | Time between admission and discharge from hospital or death in hospital | Until 28 days from noninvasive respiratory support initiation |
| Granollers |
| Barcelona |
| 08402 |
| Spain |
| Hospital de Bellvitge | L'Hospitalet de Llobregat | Barcelona | Spain |
| Fundació Althaia | Manresa | Barcelona | 08243 | Spain |
| Corporació Sanitària Parc Taulí | Sabadell | Barcelona | 08208 | Spain |
| Hospital Universitari Mútua Terrassa | Terrassa | Bardelona | 08221 | Spain |
| Hospital del Mar, Parc de Salut Mar | Barcelona | 08003 | Spain |
| Hospital de la Santa Creu i Sant Pau | Barcelona | 08025 | Spain |
| Hospital Vall d'Hebron | Barcelona | 08035 | Spain |
| Hospital Dr.Josep Trueta | Girona | 17007 | Spain |
| ID | Term |
|---|---|
| D000086382 | COVID-19 |
| D018352 | Coronavirus Infections |
| D045169 | Severe Acute Respiratory Syndrome |
| D012131 | Respiratory Insufficiency |
| D012140 | Respiratory Tract Diseases |
| ID | Term |
|---|---|
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
| D014777 | Virus Diseases |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012120 | Respiration Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| D045422 | Continuous Positive Airway Pressure |
| D013812 | Therapeutics |
| ID | Term |
|---|---|
| D011175 | Positive-Pressure Respiration |
| D012121 | Respiration, Artificial |
| D058109 | Airway Management |
| D012138 | Respiratory Therapy |
Not provided
Not provided